Weekly Analysts’ Ratings Updates for Varex Imaging (VREX)

Several brokerages have updated their recommendations and price targets on shares of Varex Imaging (NASDAQ: VREX) in the last few weeks:

• 12/1/2025 – Varex Imaging had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Varex Imaging had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/22/2025 – Varex Imaging was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
• 11/19/2025 – Varex Imaging had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $23.00 to $18.00. They now have an “outperform” rating on the stock.
• 11/19/2025 – Varex Imaging had its “buy” rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock.
• 10/8/2025 – Varex Imaging had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.